Shanghai Henlius Biotech
Clinical trials sponsored by Shanghai Henlius Biotech, explained in plain language.
-
New drug combo shows promise for tough lung cancer
Disease control CompletedThis study tested whether adding the drug HLX10 to standard chemotherapy helps people with extensive-stage small cell lung cancer live longer. 585 patients who had not received prior treatment were randomly assigned to get either HLX10 plus chemo or a placebo plus chemo. The main…
Phase: PHASE3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
First human test of potential IPF drug begins
Knowledge-focused CompletedThis early-stage study tested a new drug called HLX6018 in 66 healthy adults to see if it is safe and how the body processes it. The drug is being developed for idiopathic pulmonary fibrosis (IPF), a disease that scars the lungs. Participants received a single dose of the drug or…
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Knowledge-focused
Last updated May 26, 2026 10:30 UTC